Ligand News and Research

RSS
Study shows immune therapy can prevent pregnancy in mammals including humans

Study shows immune therapy can prevent pregnancy in mammals including humans

Obeticholic Acid safe and effective against Primary Biliary Cirrhosis

Obeticholic Acid safe and effective against Primary Biliary Cirrhosis

Immune therapy can control fertility in mammals

Immune therapy can control fertility in mammals

Intercept initiates OCA FLINT trial in patients with nonalcoholic steatohepatitis

Intercept initiates OCA FLINT trial in patients with nonalcoholic steatohepatitis

Prolia associated with greater adherence than alendronate in postmenopausal women with osteoporosis

Prolia associated with greater adherence than alendronate in postmenopausal women with osteoporosis

Vitamin A may play key role in sperm cell formation and development of central nervous system

Vitamin A may play key role in sperm cell formation and development of central nervous system

Plexxikon commences PLX3397 Phase 2 trial in patients with Hodgkin lymphoma

Plexxikon commences PLX3397 Phase 2 trial in patients with Hodgkin lymphoma

USPTO grants patent to Symphogen's Sym004 to treat solid tumors

USPTO grants patent to Symphogen's Sym004 to treat solid tumors

FADD protein discovery can lead to better cancer and autoimmune disease drugs

FADD protein discovery can lead to better cancer and autoimmune disease drugs

The Lancet journal publishes XGEVA Phase 3 study results against prostate cancer, bone metastases

The Lancet journal publishes XGEVA Phase 3 study results against prostate cancer, bone metastases

Trevena commences TRV120027 Phase 2a trial in patients with acute heart failure

Trevena commences TRV120027 Phase 2a trial in patients with acute heart failure

Amgen announces publication of XGEVA Phase 3 study results against solid tumors in Journal of Clinical Oncology

Amgen announces publication of XGEVA Phase 3 study results against solid tumors in Journal of Clinical Oncology

Researchers identify CD19-L protein that facilitates recognition, destruction of leukemia cells

Researchers identify CD19-L protein that facilitates recognition, destruction of leukemia cells

Scientists unravel mystery about how new tumors in individuals with breast cancer take root

Scientists unravel mystery about how new tumors in individuals with breast cancer take root

Targeted delivery combination crosses brain protecting barrier and homes in on tumors

Targeted delivery combination crosses brain protecting barrier and homes in on tumors

CyDex stockholders approve merger with Ligand

CyDex stockholders approve merger with Ligand

Ligand announces acquisition of CyDex Pharmaceuticals

Ligand announces acquisition of CyDex Pharmaceuticals

New investigative tool may explore intracellular processes with unprecedented clarity

New investigative tool may explore intracellular processes with unprecedented clarity

Salk Institute uncovers presenilin's productive side

Salk Institute uncovers presenilin's productive side

Ligand, Chiva Pharmaceuticals enter strategic relationship to develop multiple Ligand assets, technology

Ligand, Chiva Pharmaceuticals enter strategic relationship to develop multiple Ligand assets, technology